All
The HCPLive podcasts page features a feed of medical news and interview podcast series, including DocTalk, Lungcast, Derm Discussions, Rare Disease Report, and Heart Trials.
Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS
Bludorn joins Lungcast to review the increasing effects and signs of heat-related illness amid record-high temperatures.
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD
The novel potassium-competitive acid blocker now boasts 3 FDA approvals across erosive and non-erosive GERD, expanding the treatment armamentarium for patients and clinicians.
Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
In this episode, John Buse, MD, PhD, discusses the background, expected prevalence, reaction to results, and the importance of the second part of the CATALYST trial.
Endocrinology Month in Review: June 2024
In the endocrinology month in review, we spotlight top news in the endocrinology pipeline and the most important updates from ADA 2024.
Dermatology in 2024: FDA First Half Recap, with James Del Rosso, DO
Our dermatology FDA recap for the first half of 2024 includes our top 5 approvals, 3 decisions to watch in the second half of 2024, and a podcast episode with James Del Rosso, DO
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap
In this episode, hosts recaps their picks for top diabetes technology-related updates from ADA 2024, including news from Omnipod, MiniMed 780G, and the Tandem mobi.
New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD
In this episode, Veeral Sheth, MD speaks with Alkeus Pharmaceutical's CMO on the company's lead candidate for Stargardt disease and the TEASE clinical trial program.
Diabetes Dialogue: Patient Considerations for Inhaled Insulin, with Carol Levy, MD
Carol Levy, MD, discusses INHALE-3 trial and how to incorporate individual patient-level factors into the management of patients with type 1 diabetes who could benefit from inhaled insulin.
Diabetes Dialogue: Blue Circle Health, with Monica Gomberg, MD
Monica Gomberg, MD, joins the podcast to discuss how Blue Circle Health leverages free support and education programs to improve management and quality of life in people with types 1 diabetes.
Diabetes Dialogue: Advances in AID and CGM at ADA 2024, with Davida Kruger, NP
Davida Kruger, NP, joins the podcast to discuss updates in automated insulin delivery and continuous glucose monitoring systems from ADA 2024.
Stopping Lung Cancer Before It Starts with Steven Dubinett, MD, and Avrum Spira, MD
Dubinett and Spira rejoin Lungcast for an update on their team's research into lung cancer interception.
Diabetes Dialogue: New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN
Anastasia Albanese-O'Neill, PhD, APRN, joins Diabetes Dialogue to discuss newly released consensus guidance on monitoring of early-stage type 1 diabetes spearheaded by Breakthrough T1D.
Diabetes Dialogue: ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD
In the special on-site ADA 2024 episode, hosts are joined by the ADA's Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, to discuss the newly formed Obesity Association.
Diabetes Dialogue: INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD
In this episode, hosts are joined by Grazia Aleppo, MD, for a discussion on the use of inhaled insulin following the INHALE-3 trial and relevant updates in diabetes technology at ADA 2024.
Diabetes Dialogue: June 2024 Updates in Diabetes Tech and Type 1 Diabetes
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
New Insight: A Look at the OcuLenz with Michael Freeman, CEO of Ocutrx
Michael Freeman joins Veeral Sheth, MD to discuss the history of Ocutrx, its OcuLenz and OR-Bot products, and what he envisions in the next decade at the company.
The Changing Community-Acquired Pneumonia Landscape with Thomas File, MD, MSc, MACP
File joins Lungcast to review the ATS-IDSA 2019 guideline updates for community-acquired pneumonia, and advances to diagnostics and care.
Diabetes Dialogue: GLAM and CRISTAL, Updates in Pregnancy
In this episode, hosts provide their audience with an overview of a pair of new studies on the topic of diabetes in pregnancy: the GLAM and CRISTAL studies.
Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Brendon Neuen, MBBS, PhD, joins the podcast to discuss the latest updates in nephrology, including the landmark FLOW trial.
Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.
Community-Based Asthma Challenges and Solutions, with Stephanie Lovinsky-Desir, MD, MS
Lovinsky-Desir joins Lungcast on World Asthma Day to discuss community-specific burdens of disease, and emerging strategies to manage it.
John Balmes, MD: How to Advocate for Air Quality Improvement
In this Lungcast episode segment, Balmes spoke about advocating for air pollution improvements, inequities in air quality, and more.
Air Quality Issues Due to Particle Pollution with John Balmes, MD
This segment of the latest Lungcast episode featured a discussion over the ALA’s State of the Air Report and the impacts of particle pollution.
2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD
Balmes discusses the latest annual State of the Air Report, which shows that 131 million Americans are living in areas with failing air quality grades.
Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations
In this episode, hosts break down the latest type 2 diabetes recommendations from the American College of Physicians and offer their perspective on second-line therapies in T2D.
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts discuss the STEP HFpEF DM trial and the need for fair allocation of incretin-based therapies with ongoing shortages and overwhelming demand.
Post-COVID Transplants, Long COVID Impacts with Kenneth McCurry, MD & Maryam Valapour, MD, MPP
In the latest Lungcast, Drs. McCurry and Valapour answered several questions on the candidacy of post-infectious COVID-19 patients for lung transplantation and on long COVID.
Don't Miss a Beat: EMPACT-MI at ACC.24, with Javed Butler, MD
In this ACC.24 episode of Don't Miss a Beat, hosts are joined by Javed Butler, MD, for a breakdown of the EMPACT-MI trial.
Recent Changes in Lung Allocation with Kenneth McCurry, MD & Maryam Valapour, MD, MPP
During this segment of Lungcast, Valapour and McCurry discussed recent changes made to lung allocation scores as well as the topic of graft rejection.
Endocrinology Month in Review: March 2024
In this endocrinology month in review for March 2024, we recap the most popular FDA news and pipeline updates as well as recognizing the 2-year anniversary of Diabetes Dialogue.